Hims vs Metabolyz
Hims and Metabolyz sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
Metabolyz
Best for: coaching bundled into the price rather than sold separately
Visit Metabolyz →If you are choosing between Hims and Metabolyz, price alone will not settle it. Hims leads our six-part score, 6.8 to 4.7. One of the two has an FDA warning letter on record, covered below.
Hims vs Metabolyz price
Hims publishes $199 a month. Metabolyz does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hims lists semaglutide and tirzepatide; Metabolyz does not name its drug.
On format, Hims prices compounded injections and brand-name pens, while Metabolyz posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Hims lists 50 states, and Metabolyz lists 50 states.
They overlap in 50 states.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
Metabolyz
Pricing not publicly listed.
What each price covers
Both prices cover the medication itself.
Metabolyz's price also covers the clinician visit, shipping and coaching, which Hims does not claim.
Hims is silent on shipping and lab work.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Metabolyz
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Charged on top
Coaching
In the price
Where each one scores higher
Overall, Hims scores 6.8 and Metabolyz 4.7 out of 10.
Hims is stronger on effectiveness (10.0 vs 5.0), user experience (8.0 vs 3.0) and trust & safety (7.0 vs 5.0).
Metabolyz is stronger on support (5.0 vs 3.0).
Value and accessibility are within half a point.
Hims
6.8/10
Metabolyz
4.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Metabolyz has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | Metabolyz |
|---|---|---|
| Starting Price | $199/mo | Not published |
| Features | 2 features | ✓8 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About Metabolyz
No figure is posted; you hear it at the first consultation. Three compounded tracks exist, one of them a microdose protocol for people who cannot tolerate standard doses or who are close to goal weight, the other two standard semaglutide and dual-agonist tirzepatide. Coaching on lifestyle and nutrition is built in, delivery is temperature-controlled, US pharmacies holding 503A/503B licenses supply the drug, and a physician supervises in all 50 states.
Read our full Metabolyz review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Metabolyz
What we like
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves all 50 states
- We found no FDA warning letters issued to Metabolyz
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Not included in the monthly price: lab work
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hims wins this one, 6.8 to 4.7, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. Metabolyz fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Choose Metabolyz if…
You want coaching bundled into the price rather than sold separately.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
MEDGm
Month-to-month compounded semaglutide at $179 with the partner pharmacies named
From $179/mo
Get started →HumeCare+
An oral route if you will not self-inject
From $199/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Hims vs Metabolyz: FAQ
Close alternatives to Hims and Metabolyz
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- Metabolyz vs Embody
- Metabolyz vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.